T HYROID follicular cells provide a useful model system in which to study the molecular components of both proliferation and differentiation signaling pathways. The glycoprotein hormone TSH, is one of the crucial regulators of thyrocytes.
Like many other hormones, TSH regulates both growth and differentiated function.
In an oxidative coupling reaction requiring H,O,, thyroperoxidase attaches circulating iodide to thyroglobulin (Tg), a structural precursor to thyroid hormone. Degradation of iodinated Tg by lysosomal proteases leads to the production of the thyroid hormones T, and triiodothyronine.
Numerous studies have established a vital role for TSH in the regulation of Tg (3,4), thyroperoxidase (5, 6), TSH receptor gene expression (7-9), iodide uptake and metabolism.
In addition to its role in regulating thyroid hormone biosynthesis, TSH stimulates DNA synthesis and proliferation in follicular cells from a variety of species, including human (lo), dog (11) and rat (12, 13). The signaling pathways through which TSH stimulates growth and differentiated function are at least partially shared. TSH binds to a seven transmembrane-spanning domain receptor that is coupled to the heterotrimeric G proteins G, and G,],, (14) . Activation of G, leads to the stimulation of adenylyl cyclase, the production of the second messenger CAMP and activation of the CAMP-dependent protein kinase (cAPK). Many of the effects of TSH on proliferation and differentiation can be mimicked by forskolin and CAMP analogs, indicating that these effects are mediated through CAMP. Detailed study of the rat and human Tg promoters revealed that although these promoters do not contain previously described CAMP response elements (CREs), they do contain a CAMP-responsive region (15). We recently demonstrated that the Ras protooncogene functions in TSH growth signaling pathways (1, 16 where Results
TSH stimulates Tg expression in WRT cells
TSH has been shown to stimulate Tg messenger RNA (mRNA) (4, 26) and protein expression in thyrocytes derived from several species. To confirm that TSH exerted similar effects in WRT cells, Tg expression was monitored using a polyclonal antibody raised against the Tg gene product. Because WRT cells are propagated in TSH and Tg is a stable protein, WRT cells were incubated in basal medium devoid of TSH for 6 days before treatment to decrease Tg expression. Under these conditions, basal levels of Tg protein were quite low (Fig. 1A) . Stimulation with TSH for 24 h dramatically increased Tg protein levels (Fig. 1B ) in a dose-dependent manner ( Fig. 2A) . Tg expression was maximal in response to 1 mu/ml TSH. Higher concentrations (up to 10 mu/ml) failed to further increase the number of cells expressing Tg ( Fig. 2A) . However, TSH at concentrations greater than 0.3 mu/ml induced cell rounding, making it difficult to discriminate between Tg expressing and nonexpressing cells in immunostaining experiments. Therefore, 0.3 mu/ml TSH was used to induce Tg expression; TSH at this concentration stimulates high levels of Tg expression, whereas the cells retain a flat morphology (Fig. 1B) . Similar to TSH, forskolin and 8BrcAMP also stimulated Tg expression (Fig. 2B ) demonstrating that the effects of TSH on Tg expression are mediated at least partly through CAMP in these cells as has been reported in other follicular cells.
Acute or chronic expression of Ras reduces TSH-stimulated Tg expression
Microinjection of cellular or oncogenic Ras stimulates DNA synthesis in quiescent WRT cells (13). In addition, maximal levels of TSH stimulated DNA synthesis require Ras (1 (Fig. 3, A and B) . Unlike parental WRT cells (Fig. 3C) , the Ras-transfected cells exhibited reduced levels of Tg expression in response to TSH (Fig. 3D) . Taken together, these results indicate that either acute or chronic overexpression of H-Ras significantly reduces TSHstimulated Tg expression.
Microinjection
of Ras has no effect on the nuclear localization or activity of C subunit
In a single clone of azacytidine treated FRTL-5 cells, expression of K-Ras inhibited Tg expression by reducing nuclear C subunit activity (2). In WRT cells, Ras is required for TSHstimulated DNA synthesis (11, which also requires entry of C subunit into the nucleus. Injection of the thermostable protein kinase inhibitor (PKI) restricts C subunit to the cytoplasm (25, 27, 28) and reduces TSH-stimulated DNA synthesis (1). To begin to investigate the mechanism through which Ras inhibits Tg expression in WRT cells, the effects of Ras on the intracellular distribution of C subunit were assessed. Injection of oncogenic Ras 2 or 16 h before injection of fluorescently labeled purified C subunit did not prevent its nuclear accumulation (not shown). In three separate experiments (129 injected cells), there was no discernible effects of injected Ras on the intracellular distribution of microinjected C subunit. Because the levels of injected C subunit in these experiments exceeded intracellular concentrations, we also examined the effects of Ras on TSH-stimulated translocation of endogenous C subunit. Injection of oncogenic Ras into quiescent WRT cells before treatment with TSH did not restrict endogenous C subunit from entering the nucleus as assessed by immunostaining with an antibody raised against C subunit (Fig. 4) . Staining for free C subunit was low in quiescent WRT cells (Fig. 4B) . Injection of oncogenic Ras had no effect on C subunit staining (compare arrowed injected cells to other cells in 4B). After stimulation with TSH (Fig. 4E) or 8BrcAMP (Fig.  4H ) for 60 min, increased levels of C subunit could be detected in the nucleus. Counterstaining with Hoechst revealed that C subunit staining was localized largely to the nucleus (compare Fig. 4E and 4H with 4F and 41). The nuclear distribution of C subunit was not affected by prior injection of oncogenic Ras (compare mowed injected cells to other cells in Fig. 4E and 4H ). Because the immunostaining experiments were not quantitative, it was possible that Ras reduced diffusion of C subunit into the nucleus resulting in nuclear levels of free C subunit too low to stimulate changes in gene expression. To test this idea, the effects of Ras on one of the nuclear substrates of C subunit, the + transcription factor CREB, were examined. CREB is a nuclear phosphoprotein that is constitutively bound to CRE-containing promoters (29). The transcriptional activity of CREB is stimulated after its phosphorylation at serine 133 by C subunit. Entry of C subunit into the nucleus appears to be the rate limiting step in CREB activation (30). The effects of Ras on TSH-stimulated CREB phosphorylation were assessed in immunostaining experiments using an antibody that specifically recognizes CREB phosphorylated at serine 133. Although phosphorylated CREB was undetectable in quiescent cells (Fig. 5A) , stimulation with TSH stimulated high levels of phosphoCREB staining (Fig. 5B) . The effects of TSH were mimicked by cholera toxin and 8BrcAMP, but not by the phorbol ester TEA, indicating that they were mediated through cAPK (data not shown). Injection of oncogenic Ras had no effect on the ability of TSH to stimulate CREB phosphorylation (Fig. 5 , C and D; Table 2 ). Similar effects were observed in response to 8BrcAMP. Because CREB phosphorylation occurs in the nucleus, these results indicate that acute expression of Ras does not interfere with the entry of C subunit into the nucleus and its activity towards CREB in WRT cells.
Elevations in CAMP mediated by TSH, cholera toxin, forskolin, or 8BrcAMP treatment, stimulate P-galactosidase expression in WRT cells stably transfected with a CRE-regulated 1acZ gene (WRT CRE cells) (Refs. 13 and 31 and Table  3 ). In addition, CRE-regulated gene expression in response to TSH or 8BrcAMP is abolished after microinjection of PKI or a mutant type I regulatory subunit (1,28) demonstrating that these effects are mediated solely through cAPK. To assess if Ras affected TSH-stimulated gene expression, quiescent WRT CRE cells were injected with oncogenic Ras and then incubated for 6 h in the presence or absence of TSH or SBrcAMP. Injection of oncogenic Ras alone had no stimulatory effect on CRE-regulated gene expression (Table 3) . Moreover, injection of oncogenic Ras did not reduce TSH-or 8BrcAMP-stimulated CRE-regulated gene expression (Table  3) . These results differ from those reported previously where Ras inhibited entry of C subunit into the nucleus (2). In these cells, the effects of Ras were mimicked by treatment with TPA. To determine if TPA inhibited the early events stimulated by TSH, the effects of TPA on TSH-stimulated CREB phosphorylation, CRE-regulated gene expression, and Tg expression were examined. TPA had no effect on either TSHstimulated CREB phosphorylation (Table 2) or CRE-regulated gene expression (Table 3) . However, similar to previous reports, TPA reduced TSH-stimulated Tg expression (Fig. 6) . Taken together, these data argue that the inhibitory effects of Ras and TPA on TSH-stimulated Tg expression in WRT cells are exerted distal to effects on C subunit trafficking to the nucleus, CREB phosphorylation, and the stimulation of CREregulated gene expression.
Discussion
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Transformation of thyroid follicular cells with a variety of oncogenes (including Ras) results in extinguished Tg expression (17,21,23,24X In previous studies, both Tg expression and promoter activity were found to be down-regulated in FRTL-5 cells transformed with a temperature-sensitive K-l& construct (32). Although still unclear, it appears that some of the effects of Ras on Tg expression are mediated through the thryoid specific transcription factor 1 UTF-1). In cells exposed to Ras for short times and then shifted to the nonpermissive temperature, lTF-1 activity was restored by treatment of nuclear extracts with cAPK, suggesting that Ras and cAPK exert opposing effects onTTF-1 activity (21). In cells exposed to Ras for prolonged periods, Tg expression was no longer restored by temperature shift but could be restored after treatment with the demethylating agent, 5-azacytidine. In one such clone where Tg expression was restored, re-expression of Ras abolished Tg expression and reduced nuclear C subunit activity (2). Because only a single clone was examined, it remains unclear if this is a general mechanism through which Ras inhibits Tg expression. Moreover, these results are difficult to reconcile with other findings that indicate that nuclear translocation of C subunit is required for TSH-stimulated proliferation. For example, microinjection of the thermostable PKl (25,27,28) or of a mutant type I regulatory subunit (wen, W., and J. L. Meinkoth, manuscript in preparation), both of which sequester C subunit in the cytoplasm reduced TSH-stimulated DNA synthesis. These results suggest that entry of C subunit into the nucleus is required for the mitogenic effects of TSH. Additionally, together TSH and Ras stimulate more cells to enter S phase than either agent alone (16), an effect that would not be expected if Ras inhibited nuclear entry of C subunit. Similarly, overexpression of a dominant negative form of CREB reduced TSH-stimulated DNA synthesis and growth rate in FRTL-5 cells, confirming a role for CREB in thyrocyte proliferation (33). Because CREB is phosphorylated by C subunit in the nucleus (34) and it is the phosphorylated form of CREB that is transcriptionally active (35), this further supports the notion that nuclear activity of C subunit is required for TSH-stimulated proliferation. To better understand the effects of Ras on early events associated with TSH signaling, several components of TSH signaling were examined in cells microinjected with purified Ras protein. These results demonstrate that even acute expression of Ras is sufficient to down-regulate TSH-stimulated Tg expression. However, in contrast to earlier studies, acute expression of Ras did not inhibit the early events associated with CAMP-mediated signaling. Microinjection of either cellular or oncogenic H-Ras had no discernible effect on the nuclear distribution of exogenous or endogenous C subunit. When coinjected with fluorescently labeled C subunit, Ras failed to restrict C subunit to the cytoplasm. Similarly, injection of Ras had no effect on the TSHstimulated translocation of endogenous C subunit. Consistent with these results, Ras injection did not prevent CREB phosphorylation in response to TSH or SBrcAMP, an event that occurs in the nucleus. Ras also failed to affect CRE-regulated gene expression either when injected alone or when injected into cells that were subsequently stimulated with TSH. 
